Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study
Aly A Yousef,1 Faisal Y Mohamed,2 Naglaa F Boraey,3 Nagwa E Akeel,4 Attia A Soliman,4 Nevin M Waked,5 Mustafa IA Hashem,4 Hassan Shehata,4 Dalia S Fahmy,6 Ali Ismael,7 Lamya M Ibrahim,8 Mohamed AM Ibrahim,9 Hanan F Salem,10 Sherif M Yousry,11 Sherif F Osman,12 Rania A Fouad,13,14 Eman T Enan,15,16 M...
Guardado en:
Autores principales: | Yousef AA, Mohamed FY, Boraey NF, Akeel NE, Soliman AA, Waked NM, Hashem MIA, Shehata H, Fahmy DS, Ismael A, Ibrahim LM, Ibrahim MAM, Salem HF, Yousry SM, Osman SF, Fouad RA, Enan ET, Attia MA, Afify MR, Zeidan NMS, Nashat M |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2020
|
Materias: | |
Acceso en línea: | https://doaj.org/article/1abd069844a54c6894f02e1129a8c57d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Association of Plasminogen Activator Inhibitor 1 (PAI-1) 4G/5G Polymorphism and Susceptibility to SLE in Egyptian Children and Adolescents: A Multicenter Study [Corrigendum]
por: Yousef AA, et al.
Publicado: (2021) -
Autoimmune Thrombocytopenia in SLE and COVID-19
por: Yeremia Suryo Pratama, et al.
Publicado: (2021) -
Activity Disease in SLE Patients Affected IFN-γ in the IGRA Results
por: Maharani W, et al.
Publicado: (2020) -
Hypocalcemia and massive pulmonary embolism in SLE patient with COVID‐19 infection: A case report
por: Mohammed Yousif Elnaeem Yousif, et al.
Publicado: (2021) -
PLASMINOGEN ACTIVATOR OF YERSINIA PESTIS
por: V. V. Evseeva, et al.
Publicado: (2015)